Scalp cooling for cancer patients

Scalp cooling is changing the face of cancer, by helping thousands of people keep their hair while undergoing treatment for chemotherapy.

Cancer affects people in different ways, but one of the most traumatic side effects of chemotherapy is hair loss. The process can make a patient feel like they are losing control of their body and their appearance, at what is already an extremely difficult time in their life. Chemotherapy does not have to mean hair loss though, as many people across the UK and throughout the world are finding out after using a pioneering scalp cooling technology. 

Developed in Huddersfield, the Paxman Scalp Cooling System is changing the face of cancer, by helping thousands of people keep their hair while undergoing treatment for chemo.1 Scalp cooling (the cold cap) can be used with all solid tumour cancers that are treated with chemotherapy drugs such as taxanes (e.g. docetaxel), alkylating agents (e.g. cyclophosphamide) and anthracyclines/DNA intercalating agents (e.g. doxorubicin). These drugs target rapidly dividing cells and the matrix keratinocytes, which results in hair loss. 

Scalp cooling cannot be used with the following conditions: 

Log in or register FREE to read the rest

This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text. If you don't already have an account, please register with us completely free of charge.

Latest Issues

EBME Expo 2025

Coventry Building Society Arena, UK
25th - 26th June 2025

AfPP Annual National Conference

University of Warwick
8th - 9th August 2025

Clinical Engineering Conference

Stansted Radisson Blu
23rd September 2025

Infection Prevention 2025

Brighton Centre, UK
29th - 30th September 2025